HTR2A rs6311: Understanding the Serotonin Receptor Variant
The rs6311 variant is a single nucleotide polymorphism located in the promoter region of the HTR2A gene. It is frequently studied for its potential influence on serotonin receptor expression, which may play a role in mood regulation, sleep patterns, and various psychiatric conditions.
What each genotype means
Potential altered receptor expression
This genotype is located in the promoter region of the HTR2A gene and has been studied for its role in regulating serotonin receptor expression and methylation. Some research suggests that individuals with this genotype may show different patterns of susceptibility to certain psychiatric conditions compared to those with the G allele, though findings across studies remain inconsistent. Please discuss any concerns regarding mood or sleep health with your healthcare provider.
This genotype is found in various global populations, with frequencies varying significantly by ancestry.
Typical receptor expression profile
Carrying one copy of each allele means your genetic profile for this HTR2A variant is heterozygous. Research into this variant often focuses on how it influences serotonin receptor activity, but the clinical significance of carrying one A and one G allele is not definitively established. As with any genetic finding related to mood or sleep, this should be viewed as one small piece of a much larger biological picture.
This is a common genotype observed frequently across many diverse ancestral groups.
Potential altered receptor expression
This genotype has been investigated in studies regarding serotonin receptor expression levels and potential associations with psychiatric traits. While some research has linked the G allele to specific clinical outcomes, other studies have reported contradictory or negative results, indicating that the evidence is limited. You should consult with a clinician if you have questions about how your genetics might relate to your personal health history.
This genotype is widely distributed, though its prevalence varies depending on the specific population studied.
What is the rs6311 Variant?
The rs6311 variant, often referred to as the -1438G/A polymorphism, is a specific change in the DNA sequence located within the promoter region of the HTR2A gene on chromosome 13. A promoter region acts as a control switch for a gene, determining how much of a protein is produced. Because rs6311 sits in this regulatory area, researchers investigate whether the presence of a G or an A allele alters the binding of transcription factors—proteins that turn genes on or off. By influencing how the HTR2A gene is expressed, this variant may affect the density or sensitivity of serotonin receptors in the brain. While it is a well-documented site in genomic research, it is important to note that genetic variants rarely act in isolation; they often interact with environmental factors, epigenetic modifications, and other genes to influence biological outcomes.
The Role of the HTR2A Gene
The HTR2A gene provides instructions for creating the 5-hydroxytryptamine receptor 2A, commonly known as the serotonin 2A receptor. Serotonin is a vital neurotransmitter that acts as a chemical messenger in the brain, helping to regulate mood, sleep, appetite, and cognitive functions. The 5-HT2A receptor is a primary target for many medications, including certain antidepressants and antipsychotics, as well as various hallucinogenic substances. Because this receptor is widely distributed throughout the central nervous system, it is involved in complex processes like sleep architecture and emotional processing. Variations in the HTR2A gene, such as rs6311, are of interest to scientists because they may change the abundance of these receptors, potentially shifting the balance of serotonin signaling and contributing to individual differences in how people respond to stress or maintain healthy sleep cycles.
Research and Evidence Strength
Scientific evidence linking rs6311 to specific health outcomes is considered limited and often inconsistent. While some studies have observed associations between this variant and conditions such as depression, schizophrenia, obsessive-compulsive disorder, and chronic fatigue syndrome, these findings are not always replicated across different populations. For instance, some research suggests that the A allele might create a binding site for the E47 transcription factor, potentially altering receptor expression levels. However, the clinical significance of these molecular changes remains a subject of ongoing debate. Because many of these studies are based on candidate gene approaches rather than large-scale genome-wide association studies, the effect sizes are generally small. Consequently, rs6311 should be viewed as a marker of interest in psychiatric genetics rather than a definitive diagnostic tool for any medical condition.
Interpreting Your Genetic Information
It is essential to understand that having a particular genotype for rs6311 does not determine your health or behavior. Genetic associations are statistical observations made across large groups of people, not individual predictions. You cannot use this information to diagnose yourself with a sleep disorder, mood condition, or any other health issue. If you are concerned about your sleep quality, mood, or mental health, please consult a qualified healthcare professional. Furthermore, if you are currently taking medications that target the serotonin system, do not make any changes to your treatment plan based on genetic data. Always discuss your medication dosing and any potential concerns with your clinician or pharmacist, as they can provide guidance based on your full clinical history rather than a single genetic variant.
How common is this variant?
The rs6311 variant is common, with a global minor allele frequency reported at approximately 0.44 in major genomic databases.
Frequently asked questions
Can rs6311 predict if I will have depression?
No. While some studies have explored associations between rs6311 and depression, it is not a predictive test. Depression is a complex condition influenced by many genetic, environmental, and lifestyle factors.
Does this variant affect how antidepressants work?
Some research investigates the role of HTR2A in medication response, but the evidence is not sufficient to guide clinical treatment. Always consult your doctor before making changes to your medication.
Is rs6311 the same as other HTR2A variants?
No, rs6311 is a specific location in the promoter region. Other variants in the HTR2A gene, such as rs6314, are distinct and may have different biological effects.
Where can I find more information on this SNP?
You can explore databases like the GWAS Catalog or NCBI's dbSNP for technical data. For health-related questions, always rely on information provided by your healthcare provider.
Sources & further reading
Educational information only, last refreshed 10/4/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs6311?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in HTR2A
Recent clinical reviews indicate that HTR2A variants do not currently support actionable clinical antidepressant guidance.
Missense variant (His452Tyr) in the serotonin 5-HT2A receptor that alters downstream signaling and associates with modified slow-wave sleep and subjective sleep maintenance insomnia.
Promoter variant in HTR2A associated with sleep architecture and mood resilience.